SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of the nCounter® ...
More than 35 Abstracts Demonstrate the Value of the nCounter Platform for Targeted Discovery, Biomarker Development and Diagnostic Applications in Cancer Research and Immuno-Oncology NanoString’s New ...
NanoString's Prosigna tests works with its nCounter analyzer.--Courtesy of NanoString NanoString ($NSTG) is working to expand the adoption of its breast cancer ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc. (NASDAQ: NSTG), a leading provider of life science tools for discovery and translational research, announced today that a team of globally ...
SEATTLE--(BUSINESS WIRE)--NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results